
Tibsovo — which is the first targeted therapy approved for this patient population — improved survival in patients with a subtype of liver cancer.

Tibsovo — which is the first targeted therapy approved for this patient population — improved survival in patients with a subtype of liver cancer.

A patient with pancreatic cancer discusses how far words of kindness can go to individuals dealing with pain and suffering.

A survivor of myxofibrosarcoma expresses his thoughts about cancer recurrence and treatment options in a poem.

A patient details how a nurse made her experience with blood draws, which can be difficult due to compromised veins, a much more pleasant one.

A retired oncology social worker offers several tips on supporting a friend who has cancer, as well as ways to ask for support as a patient with cancer.

A woman with triple positive breast cancer shares an ode to her scars in hopes that other cancer survivors will find solace and connection in her words.

“I like to think the people of Bodie counted every day and made every day count, as hard as their lives were, reminding me to do the same,” writes a woman with metastatic breast cancer about her visit to Bodie State Historic Park.

The approval of Welireg, according to an expert at Massachusetts General Hospital, is “extremely important” and will “dramatically” change how certain von Hippel-Lindau-associated cancers are treated.

The benefits obtained with antihypertensive medications in colorectal cancer may indicate potential mechanisms that act against tumor cells.

Patients with blood cancers may be less likely to derive immunity from the COVID-19 vaccine, though antibody tests should not be the end-all-be-all in guiding their behavior.

Researchers are evaluating the safety and efficacy of zandelisib, an investigational cancer therapy, for the treatment of patients with marginal zone lymphoma and follicular lymphoma who have received at least two prior therapies.

A recently approved antibody-drug conjugate provides another much-needed treatment choice for patients with locally advanced and metastatic urothelial cancer.

A caregiver discusses her wishes for a woman who was recently diagnosed with metastatic breast cancer. “Most of all I wish that time will stand still for her, so that she can crawl into bed with her children and hold them as long as she wants to, feeling their bodies curl into hers as they sleep,” she writes.

Acting FDA Commissioner Dr. Janet Woodcock said in a statement that hopefully the full approval of Pfizer’s COVID-19 vaccine will make people more confident in becoming vaccinated.

This contraceptive method may provide more benefits beyond contraception, but more research is needed in this area.

Khloe’s story is as unique as the rare neuroendocrine (NET) cancer she was diagnosed with in 2018. The medical team spanned three states including a NET specialist in pediatrics. Part 1 of this series introduces you to Khloe, her family and the beginning of a challenging journey.

“I didn’t think that we were involved in great change, but then change became the name of the game.” — Loretta Ford

A woman writes a poem about her varying experiences with cancer, from surviving to losing both her father and father-in-law.

From blankets to coupons, one oncology nurse makes sure that her patient has what they need before, during and after cancer treatment.

A colleague nominates Jody Ruth Steinhardt for the Lung Cancer Heroes® award for her commitment to changing the world for patients with lung cancer.

Fitting at least one relaxing, positive moment into your schedule each day has the potential to improve your overall well-being, explains one cancer survivor.

A patient nominates her oncology nurse, who stood by her side when receiving chemotherapy for nearly a year.

A woman who was diagnosed with stage 4 ovarian cancer shares a poem about dealing with the obstacles of a health crisis and the struggles of life in general.

Combining PI3 kinase inhibitors with BTK inhibitors can mitigate side effects traditionally seen with PI3 kinase inhibitors, according to recent research.

Preliminary results of the phase 2 trial assessing the safety and efficacy of Cosela with gemcitabine/platinum-based chemotherapy and Bavencio maintenance therapy for metastatic bladder cancer are expected to be released in the second half of 2022.

The FDA granted approval to Opdivo as an adjuvant treatment in patients with high-risk urothelial carcinoma.

A survivor describes the small joys in life and how she avoids letting cancer get in the way.

From Dick Vitale’s early melanoma cancer detection to the authorization of COVID-19 vaccine booster shots for patients with cancer, here’s what’s happening in the cancer landscape this week.

Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although patients should be monitored for side effects that can be easily managed.

A breast cancer survivor expresses her emotions in a poem about all that cancer has taken from her.